Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Mease

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Clinical Therapeutics|December 26, 2008
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trialDaniel J Clauw, Philip Mease, Robert H Palmer, et al.
Rheumatology (Oxford, England)|June 16, 2010
Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegolJohanna M Hazes, Peter Taylor, Vibeke Strand, et al.
BMC Musculoskeletal Disorders|September 22, 2010
Fatigue in fibromyalgia: a conceptual model informed by patient interviewsLouise Humphrey, Rob Arbuckle, Philip Mease, et al.
Arthritis Care & Research|February 24, 2025
Sex-Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta-AnalysisAngel Gao, Jordi Pardo Pardo, Steven Dang, et al.
Advances in Therapy|January 5, 2023
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced TherapyA Mark Fendrick, Philip Mease, Matthew Davis, et al.
Autoimmunity Reviews|January 1, 2025
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping reviewDimitris Challoumas, Cameron Simpson, Matthew Arnold, et al.
The Lancet. Rheumatology|January 22, 2024
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisLihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
Seminars in Arthritis and Rheumatism|March 19, 2026
The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiativeSharmila Khot, Mary Cowern, Chris Djurtoft, et al.
Arthritis Care & Research|October 22, 2020
Measuring Outcomes in Axial SpondyloarthritisAlexis Ogdie, Alí Duarte-García, Mark Hwang, et al.
Rheumatology and Therapy|March 19, 2026
A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole PatientGurjit S Kaeley, Alan Kivitz, Philip Mease, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Clinical Therapeutics|December 26, 2008
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trialDaniel J Clauw, Philip Mease, Robert H Palmer, et al.
Rheumatology (Oxford, England)|June 16, 2010
Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegolJohanna M Hazes, Peter Taylor, Vibeke Strand, et al.
BMC Musculoskeletal Disorders|September 22, 2010
Fatigue in fibromyalgia: a conceptual model informed by patient interviewsLouise Humphrey, Rob Arbuckle, Philip Mease, et al.
Arthritis Care & Research|February 24, 2025
Sex-Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta-AnalysisAngel Gao, Jordi Pardo Pardo, Steven Dang, et al.
Advances in Therapy|January 5, 2023
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced TherapyA Mark Fendrick, Philip Mease, Matthew Davis, et al.
Autoimmunity Reviews|January 1, 2025
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping reviewDimitris Challoumas, Cameron Simpson, Matthew Arnold, et al.
The Lancet. Rheumatology|January 22, 2024
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisLihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
Seminars in Arthritis and Rheumatism|March 19, 2026
The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiativeSharmila Khot, Mary Cowern, Chris Djurtoft, et al.
Arthritis Care & Research|October 22, 2020
Measuring Outcomes in Axial SpondyloarthritisAlexis Ogdie, Alí Duarte-García, Mark Hwang, et al.
Rheumatology and Therapy|March 19, 2026
A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole PatientGurjit S Kaeley, Alan Kivitz, Philip Mease, et al.
Pageof 18